Fragile X expression suppressed in either FUdR or methotrexate treated fibroblasts by pretreatment with 5-azacytidine.
D001374:Azacitidine / Q000494:pharmacology*; D002873:Chromosome Fragility / Q000187:drug effects*; D004347:Drug Interactions; D005260:Female; D005347:Fibroblasts / Q000648:ultrastructure; D005467:Floxuridine / Q000494:pharmacology*; D005786:Gene Expression Regulation; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000494:pharmacology*; D014960:X Chromosome
D005467:Floxuridine; D001374:Azacitidine; D008727:Methotrexate